Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic.

Charlotte Gotthard Mortz Henrik Fomsgaard Kjaer Trine H Rasmussen Helene M Rasmussen Lene Heise Garvey Carsten Bindslev-Jensen

Published in: Clinical and translational allergy (2022)

Hypersensitivity to excipients in COVID-19 vaccines constitutes a risk to patients with allergy to PEG or polysorbates. After diagnostic evaluation, a safe COVID-19 vaccine could be offered to most patients, the remainders will await new vaccines containing different excipients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
drug delivery
case report
patient reported outcomes
respiratory syndrome coronavirus